News
Panaxia continues growth: sums up 1st half of 2021 with 37.3 million revenues, 38.4% growth in comparison to 2020
September 2, 2021
September 2, 2021 | Yahoo! In the cumulative first six months of 2021, the company executed retail sales in Germany and Cyprus; Revenues of the 2nd
Panaxia and Neuraxpharm Expands Strategic Collaboration to Poland
August 19, 2021
August 19, 2021 | Yahoo! The companies signed an agreement for the distribution of advanced medical cannabis-based products in Poland. First sales are expected during H1
Panaxia & AxioNovo GmbH will market cannabis-based products in Germany
July 29, 2021
July 29, 2021 | MarketWatch TEL AVIV, Israel and BIELEFELD, Germany, July 29, 2021 /PRNewswire via COMTEX/ — TEL AVIV, Israel and BIELEFELD, Germany, July 29,
Panaxia and Neuraxpharm To Exclusively Distribute Medical Cannabis Extracts For Inhalation In European Market
June 21, 2021
June 21 2021 | Benzinga by Jelena Martinovic Israel’s largest manufacturer and home-delivery distributor of medical cannabis products, Panaxia Labs Israel Ltd., and its German partner Neuraxpharm received the green